H1N1 influenza virus hemagglutinin and neuraminidase antigens — Drug Target

All drugs that target H1N1 influenza virus hemagglutinin and neuraminidase antigens — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Adjuvanted inactivated influenza vaccine · Inactivated influenza vaccine

Marketed (2)

• adjuvanted Arepanrix · University of British Columbia · Adjuvanted inactivated influenza vaccine · Immunology / Infectious Disease
  Arepanrix is an adjuvanted pandemic influenza vaccine that stimulates immune response against H1N1 influenza virus through a combination of viral antigen and an immune-enhancing adjuvant.
• Anti-H1N1v Vaccine · Institut National de la Santé Et de la Recherche Médicale, France · Inactivated influenza vaccine · Immunology / Infectious Disease
  This vaccine stimulates the immune system to produce antibodies and cellular immunity against the H1N1 influenza virus.